255 related articles for article (PubMed ID: 2419161)
1. Purified calcium channels have three allosterically coupled drug receptors.
Striessnig J; Goll A; Moosburger K; Glossmann H
FEBS Lett; 1986 Mar; 197(1-2):204-10. PubMed ID: 2419161
[TBL] [Abstract][Full Text] [Related]
2. Dihydropyridine-sensitive Ca2+ channels: molecular properties of interaction with Ca2+ channel blockers, purification, subunit structure, and differentiation.
Lazdunski M; Barhanin J; Borsotto M; Fosset M; Galizzi JP; Renaud JF; Romey G; Schmid A
J Cardiovasc Pharmacol; 1986; 8 Suppl 8():S13-9. PubMed ID: 2433514
[TBL] [Abstract][Full Text] [Related]
3. Molecular approach to the calcium channel.
Glossmann H; Ferry DR; Goll A; Linn T
Adv Myocardiol; 1985; 5():41-76. PubMed ID: 2578683
[TBL] [Abstract][Full Text] [Related]
4. Positive heterotropic allosteric regulators of dihydropyridine binding increase the Ca2+ affinity of the L-type Ca2+ channel. Stereoselective reversal by the novel Ca2+ antagonist BM 20.1140.
Staudinger R; Knaus HG; Glossmann H
J Biol Chem; 1991 Jun; 266(17):10787-95. PubMed ID: 1645709
[TBL] [Abstract][Full Text] [Related]
5. (-)-[3H] desmethoxyverapamil labels multiple calcium channel modulator receptors in brain and skeletal muscle membranes: differentiation by temperature and dihydropyridines.
Reynolds IJ; Snowman AM; Snyder SH
J Pharmacol Exp Ther; 1986 Jun; 237(3):731-8. PubMed ID: 3012067
[TBL] [Abstract][Full Text] [Related]
6. (-)-[3H]Desmethoxyverapamil, a novel Ca2+ channel probe. Binding characteristics and target size analysis of its receptor in skeletal muscle.
Goll A; Ferry DR; Striessnig J; Schober M; Glossmann H
FEBS Lett; 1984 Oct; 176(2):371-7. PubMed ID: 6092142
[TBL] [Abstract][Full Text] [Related]
7. Influence of Mg++ on the effect of diltiazem to increase dihydropyridine binding to receptors on Ca++-channels in chick cardiac and skeletal muscle membranes.
Maan AC; Ptasienski J; Hosey MM
J Pharmacol Exp Ther; 1986 Dec; 239(3):768-74. PubMed ID: 2432217
[TBL] [Abstract][Full Text] [Related]
8. Temperature-dependent regulation of d-cis-[3H]diltiazem binding to Ca2+ channels by 1,4-dihydropyridine channel agonists and antagonists.
Glossmann H; Linn T; Rombusch M; Ferry DR
FEBS Lett; 1983 Aug; 160(1-2):226-32. PubMed ID: 6309565
[TBL] [Abstract][Full Text] [Related]
9. Target size analysis of skeletal muscle Ca2+ channels. Positive allosteric heterotropic regulation by d-cis-diltiazem is associated with apparent channel oligomer dissociation.
Goll A; Ferry DR; Glossmann H
FEBS Lett; 1983 Jun; 157(1):63-9. PubMed ID: 6305718
[TBL] [Abstract][Full Text] [Related]
10. High and low affinity states of the dihydropyridine and phenylalkylamine receptors on the cardiac calcium channel and their interconversion by divalent cations.
Ptasienski J; McMahon KK; Hosey MM
Biochem Biophys Res Commun; 1985 Jun; 129(3):910-7. PubMed ID: 2409972
[TBL] [Abstract][Full Text] [Related]
11. (-)-3H-desmethoxyverapamil labelling of putative calcium channels in brain: autoradiographic distribution and allosteric coupling to 1,4-dihydropyridine and diltiazem binding sites.
Ferry DR; Goll A; Gadow C; Glossmann H
Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(2):183-7. PubMed ID: 6092974
[TBL] [Abstract][Full Text] [Related]
12. Two calcium channels in basolateral membranes of rabbit ileal epithelial cells.
Homaidan FR; Donowitz M; Weiland GA; Sharp GW
Am J Physiol; 1989 Jul; 257(1 Pt 1):G86-93. PubMed ID: 2473655
[TBL] [Abstract][Full Text] [Related]
13. Voltage-dependent binding of 1,4-dihydropyridine Ca2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes.
Wei XY; Rutledge A; Triggle DJ
Mol Pharmacol; 1989 Apr; 35(4):541-52. PubMed ID: 2539561
[TBL] [Abstract][Full Text] [Related]
14. Binding of Ca2+ entry blockers to cardiac sarcolemmal membrane vesicles. Characterization of diltiazem-binding sites and their interaction with dihydropyridine and aralkylamine receptors.
Garcia ML; King VF; Siegl PK; Reuben JP; Kaczorowski GJ
J Biol Chem; 1986 Jun; 261(18):8146-57. PubMed ID: 2424894
[TBL] [Abstract][Full Text] [Related]
15. Differential labelling of putative skeletal muscle calcium channels by [3H]-nifedipine, [3H]-nitrendipine, [3H]-nimodipine and [3H]-PN 200 110.
Ferry DR; Goll A; Glossmann H
Naunyn Schmiedebergs Arch Pharmacol; 1983 Jul; 323(3):276-7. PubMed ID: 6312337
[TBL] [Abstract][Full Text] [Related]
16. Photoaffinity labelling of the cardiac calcium channel. (-)-[3H]azidopine labels a 165 kDa polypeptide, and evidence against a [3H]-1,4-dihydropyridine-isothiocyanate being a calcium-channel-specific affinity ligand.
Ferry DR; Goll A; Glossmann H
Biochem J; 1987 Apr; 243(1):127-35. PubMed ID: 2440422
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the properties of binding of calcium-channel activators and inhibitors to dihydropyridine receptors in chick heart membranes.
Maan AC; Hosey MM
Circ Res; 1987 Sep; 61(3):379-88. PubMed ID: 2441891
[TBL] [Abstract][Full Text] [Related]
18. Binding of the dihydropyridine calcium channel blocker (+)-[3H] isopropyl-4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-5-methoxycarbonyl-2, 6-dimethyl-3-pyridinecarboxylate (PN200-110) to RINm5F membranes and cells: characterization and functional significance.
Yaney GC; Stafford GA; Henstenberg JD; Sharp GW; Weiland GA
J Pharmacol Exp Ther; 1991 Aug; 258(2):652-62. PubMed ID: 1713965
[TBL] [Abstract][Full Text] [Related]
19. Heparin binds with high affinity to voltage-dependent L-type Ca2+ channels. Evidence for an agonistic action.
Knaus HG; Scheffauer F; Romanin C; Schindler HG; Glossmann H
J Biol Chem; 1990 Jul; 265(19):11156-66. PubMed ID: 2162834
[TBL] [Abstract][Full Text] [Related]
20. Calcium channels: basic properties as revealed by radioligand binding studies.
Glossmann H; Ferry DR; Goll A; Striessnig J; Schober M
J Cardiovasc Pharmacol; 1985; 7 Suppl 6():S20-30. PubMed ID: 2414589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
